Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: A multicenter study

Chinese Medical Journal

Volumn 116, Issue 2, 2003, Pages 200-202

  Li, Shirong ^a   Nie, Zhaohua ^b   Li, Nan ^c   Li, Junxiang ^d   Zhang, Ping ^e   Yang, Zhaoxu ^f   Mu, Shankun ^g   Du, Yaping ^h   Hu, Jichun ⁱ   Yuan, Shenyuan ^j   Qu, Hanting ^k   Zhang, Taichang ^l   Wang, Shixin ^m   Dong, Enyu ⁿ   Qi, Defang ^o  

^a Beijing Military Region General Hospital   (China)

^b No 261 Hospital of PLA   (China)

^c 309TH HOSPITAL OF PLA   (China)

^d Dongfang Hospital   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f General Command Hospital   (China)

^g Guangdian Hospital   (China)

^h CAPITAL MEDICAL UNIVERSITY   (China)

ⁱ CAPITAL MEDICAL UNIVERSITY   (China)

^j Beijing Haidian Hospital   (China)

^k PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^l CAPITAL MEDICAL UNIVERSITY   (China)

^m CAPITAL MEDICAL UNIVERSITY   (China)

ⁿ CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^o CAPITAL MEDICAL UNIVERSITY   (China)

more..

Author keywords

Colorectal cancer; Fecal occult blood test; Screening

Indexed keywords

GUAIAC;

ADULT; AGE; AGED; ARTICLE; CALCULATION; CANCER DIAGNOSIS; CANCER STAGING; CHINA; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMMUNITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; FEMALE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OCCULT BLOOD; PATIENT SELECTION; POPULATION RESEARCH; PREVALENCE; RELIABILITY; SCREENING TEST; SERODIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CHINA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD;

EID: 0037318840     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Li LD, Rao KQ. Statistics analysis of the motidity and mortality of malignet tumor on 11 privences and county. Chin Oncol 2000; 9:435-447.
2. Li SR. Evaluation of mass screening for colorectal cancer with "sequential fecal occult blood test" in an asymptomatic population. Chin J Oncol 1993;15:230-233.
3. Li SR, Liu DQ, Yue YW, et al. Evaluation of serial fecal occult blood test for the mass screening of colorectal cancer. Chinese Geronol J Med 1990;9:152-154.
4. Zhang YL, Zhang ZS, Yang XS, eds. Bases and clinic for colorectal cancer. Shanghai: Shanghai Science and Technology Publishing House. 1999.
5. Zhu JY, Wang YD. Clinical characteristics of youth with colorectal cancer and the cause of misdiagnosis. Endoscopy 1995;12:365-366.
6. Gao YT. Evaluation and significance of sampling investigation for malignant tumors in China from 1990-1992. Chin J Oncol 2000; 22:263-264.
7. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-1607.
8. Adami HO. Aspects of descriptive epidemiology and survival in colorectal cancer. Scand J Gastroenterol 1988;23:S6-S11.
9. Frommer DJ. What' s new in colorectal cancer screening? Gastroenterol Hepatol 1998;13:528-533.
10. Ransohoff DF, Sandler RS. Screening for colorectal cancer. N Engl J Med 2002;346:40-44.
11. Li SR, Chen ZM, Liu DQ, et al. Effect /cost of colorectal cancer screening for the population who had high risk factors. Chin J Endoscopy 1997;3:16-18.
12. Saito H. Screening for colorectal cancer: current status in Japan. Dis Colon Rectum 2000;43:S78-S84.